CD44 and neoplasm: In tumors generated by cells that were purely of the mPlum-expressing CD44+/β1+ phenotype, mPlum-expressing tumor cells consisted 27.5 ± 3.2% of the tumor mass (the rest are expected to be various stromal cells and leukocytes).